Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Dec;39(6):852–855. doi: 10.1136/gut.39.6.852

A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.

T E Bowling 1, S M Galbraith 1, A R Hatfield 1, J Solano 1, M F Spittle 1
PMCID: PMC1383458  PMID: 9038668

Abstract

BACKGROUND AND AIMS: Radiotherapy has been reported to be of benefit in prolonging the survival of patients with cholangiocarcinoma. This study examined whether radiotherapy in addition to endoscopic stenting improved survival. SUBJECTS: 56 patients with obstructive jaundice due to histologically confirmed non-resectable cholangiocarcinoma. METHODS: A retrospective analysis of these patients who were treated either with endoscopic biliary stenting followed by external beam radiotherapy and internal iridium-192 brachytherapy (n = 28) or with stenting alone (control group; n = 28). RESULTS: The two groups were well matched in age, sex, and stricture type. Eighteen patients had a type I stricture (control group: 11; radiotherapy group: 7) at the time of diagnosis and 38 had a type II or III stricture (control group: 17; radiotherapy group: 21). The median (range) overall survival from diagnosis was seven (1-29) and 10 (4-75) months in the control and radiotherapy groups respectively: This difference did not reach statistical significance (p = 0.06), but survival plots indicated a survival advantage in the radiotherapy group in the first nine months after diagnosis. Approximately one third survived longer than one year in both groups. More patients in the radiotherapy group required a stent change (1.9 v 0.9: p = 0.05), and also had a longer overall inpatient stay (42 days v 19: p < 0.001). When examined on the basis of stricture type, there was a survival advantage in the first 10 months after diagnosis in those with a type II/III stricture (seven and 11 months in the radiotherapy and control groups respectively: 0.01 < p < 0.05). There was no difference in survival between the groups in those with a type I stricture. Numbers surviving longer than one year, stent survival, and number of stent changes were all similar between the two groups when examined on the basis of stricture type, but length of hospital stay remained considerably longer in all patients receiving radiotherapy. CONCLUSION: The survival advantage of radiotherapy in those with a type II/III stricture is seen only in the first 10 months after diagnosis. The costs of radiotherapy and significantly increased time spent in hospital, however, raise doubts over its routine use in the management of non-resectable cholangiocarcinoma.

Full text

PDF
852

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander F., Rossi R. L., O'Bryan M., Khettry U., Braasch J. W., Watkins E., Jr Biliary carcinoma. A review of 109 cases. Am J Surg. 1984 Apr;147(4):503–509. doi: 10.1016/0002-9610(84)90013-8. [DOI] [PubMed] [Google Scholar]
  2. Bismuth H., Castaing D., Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988 Feb;12(1):39–47. doi: 10.1007/BF01658484. [DOI] [PubMed] [Google Scholar]
  3. Bismuth H., Nakache R., Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992 Jan;215(1):31–38. doi: 10.1097/00000658-199201000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blumgart L. H., Hadjis N. S., Benjamin I. S., Beazley R. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet. 1984 Jan 14;1(8368):66–70. doi: 10.1016/s0140-6736(84)90002-3. [DOI] [PubMed] [Google Scholar]
  5. Broe P. J., Cameron J. L. The management of proximal biliary tract tumors. Adv Surg. 1981;15:47–91. [PubMed] [Google Scholar]
  6. Busse P. M., Stone M. D., Sheldon T. A., Chaffey J. T., Cady B., McDermott W. V., Bothe A., Jr, Jenkins R., Steele G., Jr Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience. Surgery. 1989 Jun;105(6):724–733. [PubMed] [Google Scholar]
  7. Chitwood W. R., Jr, Meyers W. C., Heaston D. K., Herskovic A. M., McLeod M. E., Jones R. S. Diagnosis and treatment of primary extrahepatic bile duct tumors. Am J Surg. 1982 Jan;143(1):99–106. doi: 10.1016/0002-9610(82)90137-4. [DOI] [PubMed] [Google Scholar]
  8. Conroy R. M., Shahbazian A. A., Edwards K. C., Moran E. M., Swingle K. F., Lewis G. J., Pribram H. F. A new method for treating carcinomatous biliary obstruction with intracatheter radium. Cancer. 1982 Apr 1;49(7):1321–1327. doi: 10.1002/1097-0142(19820401)49:7<1321::aid-cncr2820490702>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  9. Ede R. J., Williams S. J., Hatfield A. R., McIntyre S., Mair G. Endoscopic management of inoperable cholangiocarcinoma using iridium-192. Br J Surg. 1989 Aug;76(8):867–869. doi: 10.1002/bjs.1800760834. [DOI] [PubMed] [Google Scholar]
  10. Fields J. N., Emami B. Carcinoma of the extrahepatic biliary system--results of primary and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1987 Mar;13(3):331–338. doi: 10.1016/0360-3016(87)90006-x. [DOI] [PubMed] [Google Scholar]
  11. Fletcher M. S., Brinkley D., Dawson J. L., Nunnerley H., Wheeler P. G., Williams R. Treatment of high bileduct carcinoma by internal radiotherapy with iridium-192 wire. Lancet. 1981 Jul 25;2(8239):172–174. doi: 10.1016/s0140-6736(81)90357-3. [DOI] [PubMed] [Google Scholar]
  12. Fletcher M. S., Brinkley D., Dawson J. L., Nunnerley H., Williams R. Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire. Br J Surg. 1983 Dec;70(12):733–735. doi: 10.1002/bjs.1800701213. [DOI] [PubMed] [Google Scholar]
  13. Fortner J. G., Vitelli C. E., Maclean B. J. Proximal extrahepatic bile duct tumors. Analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg. 1989 Nov;124(11):1275–1279. doi: 10.1001/archsurg.1989.01410110029005. [DOI] [PubMed] [Google Scholar]
  14. Gibson R. N., Yeung E., Hadjis N., Adam A., Benjamin I. S., Allison D. J., Blumgart L. H. Percutaneous transhepatic endoprostheses for hilar cholangiocarcinoma. Am J Surg. 1988 Nov;156(5):363–367. doi: 10.1016/s0002-9610(88)80187-9. [DOI] [PubMed] [Google Scholar]
  15. Hadjis N. S., Adam A., Gibson R., Blenkharn J. I., Benjamin I. S., Blumgart L. H. Nonoperative approach to hilar cancer determined by the atrophy-hypertrophy complex. Am J Surg. 1989 Apr;157(4):395–399. doi: 10.1016/0002-9610(89)90583-7. [DOI] [PubMed] [Google Scholar]
  16. Hayes J. K., Jr, Sapozink M. D., Miller F. J. Definitive radiation therapy in bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1988 Sep;15(3):735–744. doi: 10.1016/0360-3016(88)90319-7. [DOI] [PubMed] [Google Scholar]
  17. Herskovic A., Heaston D., Engler M. J., Fishburn R. I., Jones R. S., Noell K. T. Irradiation of biliary carcinoma. Radiology. 1981 Apr;139(1):219–222. doi: 10.1148/radiology.139.1.7208926. [DOI] [PubMed] [Google Scholar]
  18. Inouye A. A., Whelan T. J., Jr Carcinoma of the extrahepatic bile ducts: a ten year experience in Hawaii. Am J Surg. 1978 Jul;136(1):90–95. doi: 10.1016/0002-9610(78)90206-4. [DOI] [PubMed] [Google Scholar]
  19. Iwasaki Y., Todoroki T., Fukao K., Ohara K., Okamura T., Nishimura A. The role of intraoperative radiation therapy in the treatment of bile duct cancer. World J Surg. 1988 Feb;12(1):91–98. doi: 10.1007/BF01658492. [DOI] [PubMed] [Google Scholar]
  20. Johnson D. W., Safai C., Goffinet D. R. Malignant obstructive jaundice: treatment with external-beam and intracavitary radiotherapy. Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):411–416. doi: 10.1016/0360-3016(85)90166-x. [DOI] [PubMed] [Google Scholar]
  21. KLATSKIN G. ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med. 1965 Feb;38:241–256. doi: 10.1016/0002-9343(65)90178-6. [DOI] [PubMed] [Google Scholar]
  22. Karani J., Fletcher M., Brinkley D., Dawson J. L., Williams R., Nunnerley H. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol. 1985 Nov;36(6):603–606. doi: 10.1016/s0009-9260(85)80242-7. [DOI] [PubMed] [Google Scholar]
  23. Koyama K., Tanaka J., Kato S., Asanuma Y. New strategy for treatment of carcinoma of the hilar bile duct. Surg Gynecol Obstet. 1989 Jun;168(6):523–530. [PubMed] [Google Scholar]
  24. Kuvshinoff B. W., Armstrong J. G., Fong Y., Schupak K., Getradjman G., Heffernan N., Blumgart L. H. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg. 1995 Nov;82(11):1522–1525. doi: 10.1002/bjs.1800821122. [DOI] [PubMed] [Google Scholar]
  25. Langer J. C., Langer B., Taylor B. R., Zeldin R., Cummings B. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery. 1985 Oct;98(4):752–759. [PubMed] [Google Scholar]
  26. Levitt M. D., Laurence B. H., Cameron F., Klemp P. F. Transpapillary iridium-192 wire in the treatment of malignant bile duct obstruction. Gut. 1988 Feb;29(2):149–152. doi: 10.1136/gut.29.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Meyers W. C., Jones R. S. Internal radiation for bile duct cancer. World J Surg. 1988 Feb;12(1):99–104. doi: 10.1007/BF01658493. [DOI] [PubMed] [Google Scholar]
  28. Molt P., Hopfan S., Watson R. C., Botet J. F., Brennan M. F. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer. 1986 Feb 1;57(3):536–544. doi: 10.1002/1097-0142(19860201)57:3<536::aid-cncr2820570322>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  29. Mornex F., Gerard J. P., Bret P., Partensky C. Iridium wire radiotherapy for high bileduct carcinoma. Lancet. 1981 Aug 29;2(8244):479–479. doi: 10.1016/s0140-6736(81)90820-5. [DOI] [PubMed] [Google Scholar]
  30. Ohnishi H., Asada M., Shichijo Y., Iijima N., Itobayashi E., Shimura K., Suzuki T., Yoshida S., Mine T. External radiotherapy for biliary decompression of hilar cholangiocarcinoma. Hepatogastroenterology. 1995 Jul;42(3):265–268. [PubMed] [Google Scholar]
  31. Ottow R. T., August D. A., Sugarbaker P. H. Treatment of proximal biliary tract carcinoma: an overview of techniques and results. Surgery. 1985 Mar;97(3):251–262. [PubMed] [Google Scholar]
  32. Pilepich M. V., Lambert P. M. Radiotherapy of carcinomas of the extrahepatic biliary system. Radiology. 1978 Jun;127(3):767–770. doi: 10.1148/127.3.767. [DOI] [PubMed] [Google Scholar]
  33. Polydorou A. A., Cairns S. R., Dowsett J. F., Hatfield A. R., Salmon P. R., Cotton P. B., Russell R. C. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut. 1991 Jun;32(6):685–689. doi: 10.1136/gut.32.6.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Todoroki T., Iwasaki Y., Okamura T., Nagoshi K., Asakura H., Nakano M., Inada T., Tsunemoto H., Umegaki Y., Nishimura A. Intraoperative radiotherapy for advanced carcinoma of the biliary system. Cancer. 1980 Nov 15;46(10):2179–2184. doi: 10.1002/1097-0142(19801115)46:10<2179::aid-cncr2820461014>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  35. Tsujino K., Landry J. C., Smith R. G., Keller J. W., Williams W. H., Davis L. W. Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology. 1995 Jul;196(1):275–280. doi: 10.1148/radiology.196.1.7784581. [DOI] [PubMed] [Google Scholar]
  36. Wheeler P. G., Dawson J. L., Nunnerley H., Brinkley D., Laws J., Williams R. Newer techniques in the diagnosis and treatment of proximal bile duct carcinoma--an analysis of 41 consecutive patients. Q J Med. 1981 Summer;50(199):247–258. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES